Investigating the role of branched chain amino acids in pancreatic cancer
Branched chain amino acids and pancreatic cancer
This study is looking at how certain nutrients called branched chain amino acids might affect the growth of a tough type of pancreatic cancer, and it's for anyone interested in how diet and metabolism could play a role in cancer risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10870127 on NIH RePORTER |
What this research studies
This research focuses on understanding how branched chain amino acids (BCAAs) may influence the development of pancreatic ductal adenocarcinoma (PDA), a highly aggressive form of cancer. The study aims to explore the metabolism of BCAAs in the pancreas and their potential role in tumor formation. Using advanced techniques, including isotope tracer methods and novel mouse models, researchers will investigate how BCAA catabolism affects pancreatic function and cancer progression. The findings could provide insights into the relationship between diet, metabolism, and cancer risk.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for pancreatic cancer, such as those with obesity, diabetes, or a family history of the disease.
Not a fit: Patients with pancreatic cancer who are already undergoing treatment may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to new dietary recommendations or therapeutic strategies to reduce the risk of pancreatic cancer.
How similar studies have performed: Previous research has indicated a potential link between BCAA metabolism and cancer, suggesting that this approach may yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Wellen, Kathryn Elaine — University of Pennsylvania
- Study coordinator: Wellen, Kathryn Elaine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.